Fundz

Scinai Immunotherapeutics has received a NIS 809,000 grant from the Israel Innovation Authority to enhance its fill-and-finish capabilities, part of a NIS 1.23 million project.

PUBLIC · SCNIOct 06, 2025

Amount Raised

$246,000

Round Type

Grant

JerusalemManufacturingBiotechnologyPharmaceuticalBiopharma

Description

Scinai Immunotherapeutics Ltd. has been awarded a non-dilutive grant of approximately NIS 809,000 from the Israel Innovation Authority. This grant funds about 66% of a NIS 1.23 million project aimed at strengthening Scinai Bioservices' manufacturing capabilities. The investment will improve local access to flexible, small-scale GMP manufacturing for early-stage biotech companies

Quick answer

Scinai Immunotherapeutics Ltd raised $246,000 in a Grant round, dated October 6, 2025. Scinai Immunotherapeutics Ltd is based in Jerusalem, Jerusalem District, Israel.

How much did Scinai Immunotherapeutics Ltd raise?
Scinai Immunotherapeutics Ltd raised $246,000 in a Grant round on October 6, 2025.
What does Scinai Immunotherapeutics Ltd do?
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the..
Where is Scinai Immunotherapeutics Ltd based and how big is it?
Scinai Immunotherapeutics Ltd is based in Jerusalem, Jerusalem District, Israel. Fundz records about 32 employees.
Who are the decision-makers at Scinai Immunotherapeutics Ltd?
Fundz holds 4 contacts at Scinai Immunotherapeutics Ltd, including the Senior Consultant, pre Clinical and Clinical Development of Biologicals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biopharma around the same time

Companies in the same sectors as Scinai Immunotherapeutics Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Fennec Pharmaceuticals raised $35M (Post-IPO Equity) on November 17, 2025.
  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
  • Codis raised an undisclosed amount (Funding Round) on October 16, 2025.
  • ISOThrive raised $8.1M on October 10, 2025.
  • TORL BioTherapeutics raised $96M (Series C) on October 7, 2025.

Who to call at Scinai Immunotherapeutics Ltd, and when

A new round usually means Scinai Immunotherapeutics Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Scinai Immunotherapeutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scinai Immunotherapeutics Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scinai Immunotherapeutics Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scinai Immunotherapeutics Ltd

Location

JERUSALEM BIOPARK, 2ND FLOOR,

Jerusalem, Jerusalem District, Israel

About

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scinai Immunotherapeutics Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsTamar, Senior Consultant, pre Clinical and Cli… hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Scinai Immunotherapeutics Ltd's next move

See what Strategic adds

Scinai Immunotherapeutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.